Östör AJK - Search Results

1

Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice.

Bykerk VP, Östör AJK, Alvaro-Gracia J, Pavelka K, Román Ivorra JA, Nurmohamed MT, Luder Y, Sidiropoulos PNM, Devenport J, Sibilia J. Bykerk VP, et al. Among authors: ostor ajk. Clin Rheumatol. 2019 Sep;38(9):2411-2421. doi: 10.1007/s10067-019-04535-z. Epub 2019 Apr 26. Clin Rheumatol. 2019. PMID: 31028551

2

What's new in rheumatoid arthritis? An evidenced based review.

Ostor AJ, McColl GJ. Ostor AJ, et al. Aust Fam Physician. 2001 Apr;30(4):314-20. Aust Fam Physician. 2001. PMID: 11355216 Review.

3

Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis.

Ostör AJ, Chilvers ER, Somerville MF, Lim AY, Lane SE, Crisp AJ, Scott DG. Ostör AJ, et al. J Rheumatol. 2006 Mar;33(3):622-8. J Rheumatol. 2006. PMID: 16511933

4

Assessment of anti-TNF-alpha efficacy in rheumatoid arthritis: is 3 months sufficient?

Pocock JM, Vasconcelos JC, Ostör AJ. Pocock JM, et al. Rheumatology (Oxford). 2008 Jul;47(7):1073-6. doi: 10.1093/rheumatology/ken204. Epub 2008 May 25. Rheumatology (Oxford). 2008. PMID: 18503089

5

Abatacept: a T-cell co-stimulation modulator for the treatment of rheumatoid arthritis.

Ostör AJ. Ostör AJ. Clin Rheumatol. 2008 Nov;27(11):1343-53. doi: 10.1007/s10067-008-0964-3. Epub 2008 Aug 1. Clin Rheumatol. 2008. PMID: 18670735 Clinical Trial.

6

Genotype at the sIL-6R A358C polymorphism does not influence response to anti-TNF therapy in patients with rheumatoid arthritis.

Hassan B, Maxwell JR, Hyrich KL; Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate; Barton A, Worthington J, Isaacs JD, Morgan AW, Wilson AG. Hassan B, et al. Rheumatology (Oxford). 2010 Jan;49(1):43-7. doi: 10.1093/rheumatology/kep372. Epub 2009 Nov 19. Rheumatology (Oxford). 2010. PMID: 19926672

7

The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review.

Westlake SL, Colebatch AN, Baird J, Kiely P, Quinn M, Choy E, Ostor AJ, Edwards CJ. Westlake SL, et al. Rheumatology (Oxford). 2010 Feb;49(2):295-307. doi: 10.1093/rheumatology/kep366. Epub 2009 Nov 27. Rheumatology (Oxford). 2010. PMID: 19946022 Review.

8

Treating rheumatoid arthritis to target: recommendations of an international task force.

Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, Combe B, Cutolo M, de Wit M, Dougados M, Emery P, Gibofsky A, Gomez-Reino JJ, Haraoui B, Kalden J, Keystone EC, Kvien TK, McInnes I, Martin-Mola E, Montecucco C, Schoels M, van der Heijde D; T2T Expert Committee. Smolen JS, et al. Ann Rheum Dis. 2010 Apr;69(4):631-7. doi: 10.1136/ard.2009.123919. Epub 2010 Mar 9. Ann Rheum Dis. 2010. PMID: 20215140 Free PMC article.

9

Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review.

Westlake SL, Colebatch AN, Baird J, Curzen N, Kiely P, Quinn M, Choy E, Ostor AJ, Edwards CJ. Westlake SL, et al. Rheumatology (Oxford). 2011 Mar;50(3):518-31. doi: 10.1093/rheumatology/keq316. Epub 2010 Nov 11. Rheumatology (Oxford). 2011. PMID: 21071477 Review.

10

Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials.

Campbell L, Chen C, Bhagat SS, Parker RA, Östör AJ. Campbell L, et al. Rheumatology (Oxford). 2011 Mar;50(3):552-62. doi: 10.1093/rheumatology/keq343. Epub 2010 Nov 14. Rheumatology (Oxford). 2011. PMID: 21078627 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

126 results

Search Page